This inventor holds 1 USPTO granted patent. Top assignees: The United States Government as Represented by the Department of Veterans Affairs, University of Washington. Active years: 2026.
Company Filing History:
1 out of 953 
1 out of 2,166 
Years Active: 2026
Title: Takuma Uo: Innovator in Cancer Therapy
Introduction
Takuma Uo is a notable inventor based in Seattle, WA, who has made significant contributions to the field of cancer therapy. His innovative work focuses on the development of compounds that target glycolytic processes in cancer cells. With a single patent to his name, Uo's research has the potential to impact the treatment of prostate cancer and other diseases.
Latest Patents
Uo's most recent patent is titled "Modified pyrrolo- and pyrazolo-pyrimidines for prostate cancer therapy." This patent relates to compounds and pharmaceutical compositions that can be used to treat diseases influenced by the glycolytic generation of adenosine triphosphate (ATP). The disclosure emphasizes methods for selectively inhibiting glycolysis, which can be beneficial in treating various cancers.
Career Highlights
Throughout his career, Takuma Uo has worked with prestigious institutions, including the University of Washington and the United States Government as represented by the Department of Veterans Affairs. His work in these organizations has allowed him to collaborate with leading experts in the field of cancer research.
Collaborations
Uo has collaborated with notable colleagues such as Wesley C. Van Voorhis and Dustin James Maly. These partnerships have contributed to the advancement of his research and the development of innovative therapeutic strategies.
Conclusion
Takuma Uo's contributions to cancer therapy through his innovative patent highlight the importance of research in developing effective treatments. His work exemplifies the potential of targeted therapies in improving patient outcomes.